{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:56:03Z","timestamp":1790650563448,"version":"4.1.0"},"reference-count":60,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,21]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The TCF3::HLF fusion protein defines a highly aggressive and incurable subtype of B-cell acute lymphoblastic leukemia (B-ALL). Using a newly established mouse model that faithfully recapitulates human TCF3::HLF B-ALL, including osteolytic bone lesions, we identified self-reinforcing interleukin-1\u03b2 (IL-1\u03b2) signaling networks as a central driver of disease progression. TCF3::HLF B-ALL cells displayed marked upregulation of inflammatory cytokines, such as IL1B, IL6, and IFNG. Genetic deletion of IL1B or its receptor IL1R1 suppressed leukemic growth, reduced expression of receptor activator of nuclear factor \u03baB ligand, and ameliorated bone destruction in vivo. Epigenetic profiling revealed a previously unrecognized intronic regulatory element within the IL1B locus bound directly by TCF3::HLF. Importantly, single-cell RNA sequencing of patient samples demonstrated strong IL1B induction at relapse compared with diagnosis, underscoring its clinical relevance. Collectively, these findings establish the TCF3::HLF\u2013IL-1\u03b2 axis as a critical determinant of leukemic propagation and bone pathology and highlight IL-1\u03b2 blockade as a potential therapeutic strategy for this otherwise incurable leukemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031521","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:05:51Z","timestamp":1772557551000},"page":"2472-2488","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["Self-reinforcing IL-1\u03b2 signaling accelerates the development and recurrence of\n                    <i>TCF3<\/i>\n                    ::\n                    <i>HLF<\/i>\n                    -positive B-ALL"],"prefix":"10.1182","volume":"147","author":[{"given":"Aisa","family":"Suzuki","sequence":"first","affiliation":[{"name":"1Division of Immunology and Allergy, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5286-5108","authenticated-orcid":false,"given":"Tsukasa","family":"Shigehiro","sequence":"additional","affiliation":[{"name":"1Division of Immunology and Allergy, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Hirakawa","sequence":"additional","affiliation":[{"name":"1Division of Immunology and Allergy, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Hirano","sequence":"additional","affiliation":[{"name":"1Division of Immunology and Allergy, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minori","family":"Tamai","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8591-1281","authenticated-orcid":false,"given":"Koshi","family":"Akahane","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5855-5357","authenticated-orcid":false,"given":"Kazuo","family":"Okamoto","sequence":"additional","affiliation":[{"name":"3Division of Immune Environment Dynamics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takayanagi","sequence":"additional","affiliation":[{"name":"4Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Terashima","sequence":"additional","affiliation":[{"name":"5Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science, Shinjuku, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3871-9921","authenticated-orcid":false,"given":"Satoshi","family":"Ueha","sequence":"additional","affiliation":[{"name":"5Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science, Shinjuku, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-5230","authenticated-orcid":false,"given":"Toshimori","family":"Kitami","sequence":"additional","affiliation":[{"name":"6Laboratory for Metabolic Networks, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Takagi","sequence":"additional","affiliation":[{"name":"7Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-1636","authenticated-orcid":false,"given":"Dai","family":"Keino","sequence":"additional","affiliation":[{"name":"8Division of Hematology\/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kato","sequence":"additional","affiliation":[{"name":"9Division of Pediatric Hematology\/Oncology, Ibaraki Prefectural Children\u2019s Hospital, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"10Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7056-1020","authenticated-orcid":false,"given":"Moeko","family":"Hino","sequence":"additional","affiliation":[{"name":"11Department of Pediatrics, School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"1Division of Immunology and Allergy, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan"},{"name":"12Division of Molecular Pathology, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Inukai","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokatsu","family":"Ikawa","sequence":"additional","affiliation":[{"name":"1Division of Immunology and Allergy, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"10","key":"2026052111220908600_bib1","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/bloodadvances.2020001466","article-title":"Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features","volume":"4","author":"Zhang","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"2026052111220908600_bib2","first-page":"166","article-title":"Treatment of relapsed\/refractory acute lymphoblastic leukemia","volume":"17","author":"Paul","year":"2019","journal-title":"Clin Adv Hematol Oncol"},{"issue":"23","key":"2026052111220908600_bib3","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1200\/JCO.2010.28.8852","article-title":"Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure","volume":"28","author":"Duval","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"2026052111220908600_bib4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1200\/JCO.2009.22.2950","article-title":"Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study","volume":"28","author":"Ko","year":"2010","journal-title":"J Clin Oncol"},{"issue":"11","key":"2026052111220908600_bib5","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1038\/s41375-018-0094-0","article-title":"Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study","volume":"32","author":"Sun","year":"2018","journal-title":"Leukemia"},{"issue":"10","key":"2026052111220908600_bib6","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1172\/JCI61203","article-title":"Molecular genetics of B-precursor acute lymphoblastic leukemia","volume":"122","author":"Mullighan","year":"2012","journal-title":"J Clin Invest"},{"issue":"1","key":"2026052111220908600_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/imr.12206","article-title":"The regulatory network of B-cell differentiation: a focused view of early B-cell factor 1 function","volume":"261","author":"Boller","year":"2014","journal-title":"Immunol Rev"},{"issue":"6","key":"2026052111220908600_bib8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.immuni.2008.04.014","article-title":"Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development","volume":"28","author":"Kwon","year":"2008","journal-title":"Immunity"},{"issue":"6","key":"2026052111220908600_bib9","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.3324\/haematol.2018.210104","article-title":"Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation","volume":"104","author":"Mouttet","year":"2019","journal-title":"Haematologica"},{"issue":"5069","key":"2026052111220908600_bib10","first-page":"531","article-title":"Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia","volume":"257","author":"Inaba","year":"1992","journal-title":"Science (1979)"},{"issue":"2","key":"2026052111220908600_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/sj.leu.2404496","article-title":"Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19","volume":"21","author":"Inukai","year":"2007","journal-title":"Leukemia"},{"issue":"9","key":"2026052111220908600_bib12","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1101\/gad.6.9.1608","article-title":"Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia","volume":"6","author":"Hunger","year":"1992","journal-title":"Genes Dev"},{"issue":"11","key":"2026052111220908600_bib13","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1002\/cam4.2356","article-title":"Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy","volume":"8","author":"Watanabe","year":"2019","journal-title":"Cancer Med"},{"issue":"8","key":"2026052111220908600_bib14","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.celrep.2017.10.112","article-title":"Critical modulation of hematopoietic lineage fate by hepatic leukemia factor","volume":"21","author":"Wahlestedt","year":"2017","journal-title":"Cell Rep"},{"issue":"12","key":"2026052111220908600_bib15","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1016\/j.celrep.2017.11.084","article-title":"Hepatic leukemia factor maintains quiescence of hematopoietic stem cells and protects the stem cell pool during regeneration","volume":"21","author":"Komorowska","year":"2017","journal-title":"Cell Rep"},{"issue":"7","key":"2026052111220908600_bib16","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41556-018-0121-4","article-title":"Single-cell characterization of haematopoietic progenitors and their trajectories in homeostasis and perturbed haematopoiesis","volume":"20","author":"Giladi","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"11","key":"2026052111220908600_bib17","doi-asserted-by":"crossref","first-page":"e0143216","DOI":"10.1371\/journal.pone.0143216","article-title":"Conditional expression of E2A-HLF induces B-cell precursor death and myeloproliferative-like disease in knock-in mice","volume":"10","author":"Duque-Afonso","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"2026052111220908600_bib18","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1182\/blood.V93.9.2780","article-title":"Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia","volume":"93","author":"Honda","year":"1999","journal-title":"Blood"},{"issue":"6","key":"2026052111220908600_bib19","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1128\/MCB.19.6.4443","article-title":"Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice","volume":"19","author":"Smith","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2026052111220908600_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/leu.2010.253","article-title":"The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors","volume":"25","author":"de Boer","year":"2011","journal-title":"Leukemia"},{"issue":"6","key":"2026052111220908600_bib21","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2009-09-244673","article-title":"Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19)","volume":"116","author":"Hirose","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2026052111220908600_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1097-2765(00)80336-6","article-title":"SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein","volume":"4","author":"Inukai","year":"1999","journal-title":"Mol Cell"},{"issue":"4","key":"2026052111220908600_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1535-6108(02)00155-1","article-title":"Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo","volume":"2","author":"Inoue","year":"2002","journal-title":"Cancer Cell"},{"issue":"9","key":"2026052111220908600_bib24","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.3362","article-title":"Genomics and drug profiling of fatal TCF3-HLF\u2212positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options","volume":"47","author":"Fischer","year":"2015","journal-title":"Nat Genet"},{"issue":"6","key":"2026052111220908600_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2019.10.004","article-title":"The leukemogenic TCF3-HLF complex rewires enhancers driving cellular identity and self-renewal conferring EP300 vulnerability","volume":"36","author":"Huang","year":"2019","journal-title":"Cancer Cell"},{"issue":"2","key":"2026052111220908600_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1101\/gad.309575.117","article-title":"Three-step transcriptional priming that drives the commitment of multipotent progenitors toward B cells","volume":"32","author":"Miyai","year":"2018","journal-title":"Genes Dev"},{"issue":"7396","key":"2026052111220908600_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature11000","article-title":"Osteoprotection by semaphorin 3A","volume":"485","author":"Hayashi","year":"2012","journal-title":"Nature"},{"issue":"3","key":"2026052111220908600_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/pbc.20357","article-title":"Acute lymphocytic leukemia in adolescence with multiple osteolytic lesions and hypercalcemia mediated by lymphoblast-producing parathyroid hormone-related peptide: a case report and review of the literature","volume":"45","author":"Shimonodan","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2026052111220908600_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"2026052111220908600_bib30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/leu.2012.293","article-title":"B-lineage transcription factors and cooperating gene lesions required for leukemia development","volume":"27","author":"Tijchon","year":"2013","journal-title":"Leukemia"},{"issue":"1","key":"2026052111220908600_bib31","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1038\/ncomms7604","article-title":"Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia","volume":"6","author":"Ma","year":"2015","journal-title":"Nat Commun"},{"issue":"3","key":"2026052111220908600_bib32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccell.2015.02.003","article-title":"Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia","volume":"27","author":"Geng","year":"2015","journal-title":"Cancer Cell"},{"issue":"2","key":"2026052111220908600_bib33","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat Genet"},{"issue":"5","key":"2026052111220908600_bib34","doi-asserted-by":"crossref","first-page":"e70736","DOI":"10.1002\/cam4.70736","article-title":"Utility of a large series of B-cell precursor acute lymphoblastic leukemia cell lines as a model system","volume":"14","author":"Tamai","year":"2025","journal-title":"Cancer Med"},{"issue":"8","key":"2026052111220908600_bib35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s000110050487","article-title":"JTE-607, a novel inflammatory cytokine synthesis inhibitor without immunosuppression, protects from endotoxin shock in mice","volume":"48","author":"Kakutani","year":"1999","journal-title":"Inflamm Res"},{"issue":"1","key":"2026052111220908600_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbrc.2019.08.004","article-title":"JTE-607, a multiple cytokine production inhibitor, targets CPSF3 and inhibits pre-mRNA processing","volume":"518","author":"Kakegawa","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"issue":"D1","key":"2026052111220908600_bib37","doi-asserted-by":"crossref","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","article-title":"JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles","volume":"52","author":"Rauluseviciute","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2026052111220908600_bib38","first-page":"5986","article-title":"DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF","volume":"14","author":"Hunger","year":"1994","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2026052111220908600_bib39","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41467-019-09982-5","article-title":"CUT&Tag for efficient epigenomic profiling of small samples and single cells","volume":"10","author":"Kaya-Okur","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"2026052111220908600_bib40","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s42003-022-03536-0","article-title":"TAS-Seq is a robust and sensitive amplification method for bead-based scRNA-seq","volume":"5","author":"Shichino","year":"2022","journal-title":"Commun Biol"},{"issue":"6372","key":"2026052111220908600_bib41","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/356768a0","article-title":"A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes","volume":"356","author":"Thornberry","year":"1992","journal-title":"Nature"},{"issue":"6487","key":"2026052111220908600_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/370270a0","article-title":"Structure and mechanism of interleukin-l\u03b2 converting enzyme","volume":"370","author":"Wilson","year":"1994","journal-title":"Nature"},{"issue":"5","key":"2026052111220908600_bib43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2004.05.004","article-title":"Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases","volume":"117","author":"Martinon","year":"2004","journal-title":"Cell"},{"issue":"4","key":"2026052111220908600_bib44","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/eji.201747404","article-title":"The Gasdermin-D pore acts as a conduit for IL-1\u03b2 secretion in mice","volume":"48","author":"Heilig","year":"2018","journal-title":"Eur J Immunol"},{"issue":"6","key":"2026052111220908600_bib45","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.celrep.2018.07.027","article-title":"Interleukin-1\u03b2 maturation triggers its relocation to the plasma membrane for gasdermin-D-dependent and -independent secretion","volume":"24","author":"Monteleone","year":"2018","journal-title":"Cell Rep"},{"issue":"2","key":"2026052111220908600_bib46","doi-asserted-by":"crossref","first-page":"108998","DOI":"10.1016\/j.celrep.2021.108998","article-title":"Gasdermin E permits interleukin-1 beta release in distinct sublytic and pyroptotic phases","volume":"35","author":"Zhou","year":"2021","journal-title":"Cell Rep"},{"issue":"2","key":"2026052111220908600_bib47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"issue":"9","key":"2026052111220908600_bib48","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/cdd.2013.37","article-title":"AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC","volume":"20","author":"Sagulenko","year":"2013","journal-title":"Cell Death Differ"},{"issue":"10","key":"2026052111220908600_bib49","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.4049\/jimmunol.1301581","article-title":"Salmonella infection induces recruitment of Caspase-8 to the inflammasome to modulate IL-1\u03b2 production","volume":"191","author":"Man","year":"2013","journal-title":"J Immunol"},{"key":"2026052111220908600_bib50","doi-asserted-by":"crossref","first-page":"1125017","DOI":"10.3389\/fimmu.2023.1125017","article-title":"Insights into IGH clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications","volume":"14","author":"Darzentas","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"2026052111220908600_bib51","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/leu.2017.303","article-title":"RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"32","author":"Jerchel","year":"2018","journal-title":"Leukemia"},{"issue":"24","key":"2026052111220908600_bib52","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1182\/blood.2018864173","article-title":"Engineered Bcor mutations lead to acute leukemia of progenitor B-1 lymphocyte origin in a sensitized background","volume":"133","author":"Yin","year":"2019","journal-title":"Blood"},{"issue":"11","key":"2026052111220908600_bib53","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood.V82.11.3452.3452","article-title":"p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1\/MDR3 gene expression","volume":"82","author":"El Rouby","year":"1993","journal-title":"Blood"},{"issue":"5","key":"2026052111220908600_bib54","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.3324\/haematol.2012.076786","article-title":"TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy","volume":"98","author":"Chiaretti","year":"2013","journal-title":"Haematologica"},{"issue":"1","key":"2026052111220908600_bib55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/07853890.2018.1564359","article-title":"Prognostic significance of CDKN2A\/B deletions in acute lymphoblastic leukaemia: a meta-analysis","volume":"51","author":"Zhang","year":"2019","journal-title":"Ann Med"},{"issue":"7137","key":"2026052111220908600_bib56","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"issue":"2","key":"2026052111220908600_bib57","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"issue":"7","key":"2026052111220908600_bib58","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Isataka","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"561","key":"2026052111220908600_bib59","doi-asserted-by":"crossref","first-page":"eaba5942","DOI":"10.1126\/scitranslmed.aba5942","article-title":"B cell acute lymphoblastic leukemia cells mediate RANK-RANKL\u2013dependent bone destruction","volume":"12","author":"Rajakumar","year":"2020","journal-title":"Sci Transl Med"},{"issue":"7","key":"2026052111220908600_bib60","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/21\/2472\/2521326\/blood_bld-2025-031521-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/21\/2472\/2521326\/blood_bld-2025-031521-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:22:17Z","timestamp":1779376937000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/21\/2472\/566907\/Self-reinforcing-IL-1-signaling-accelerates-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":60,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026,5,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031521","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,21]]},"published":{"date-parts":[[2026,5,21]]}}}